Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20220222054093N1Phase 3Completed
Phase 3 trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Postoperative bleeding volume. Started Oct 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20220222054093N1.